We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Idiopathic Intracranial Hypertension Prevalence is Escalating

By HospiMedica International staff writers
Posted on 09 Feb 2021
The incidence of idiopathic intracranial hypertension (IIH) is rising considerably, corresponding to population increases in body mass index (BMI), claims a new study.

Researchers at Swansea University (United Kingdom) conducted a retrospective cohort study of 35 million patient years of routinely collected healthcare data in order to characterize trends in incidence, prevalence, and healthcare outcomes in the IIH population of Wales between 2003 and 2017; in all there were 1,765 cases of IIH in 2017 (85% of them female). More...
The researchers noted BMI, deprivation quintile, cerebrospinal fluid (CSF) diversion surgery, and unscheduled hospital admissions in both case and control cohorts.

The results showed that the prevalence of IIH in Wales increased sixfold between 2003 and 2017, with a concomitant threefold increase in incidence. This matched with obesity rates: while 29% of the study population was obese in 2003, 40% were so by 2017. IIH prevalence was also associated with increasing deprivation and destitution. Nine percent of IIH cases had CSF shunts placed, with less than 0.2% having bariatric surgery. Unscheduled hospital admissions were also higher in the IIH cohort, as compared to the control cohort. The study was published on January 20, 20201, in Neurology.

“The considerable increase in IIH incidence is multifactorial, but likely predominately due to rising obesity rates. The worldwide prevalence of obesity nearly tripled between 1975 and 2016, and therefore these results also have global relevance,” concluded senior author William Owen Pickrell, PhD, and colleagues. “Around 85% of our IIH cohort were female, similar to other studies, and we also found a significant association with increased deprivation, particularly in women.”

IIH is a condition of unknown etiology strongly associated with obesity, predominantly affecting women of childbearing age. It causes chronic disabling headaches, visual disturbance, and in a minority of patients, permanent visual loss. The definitive management is weight loss, but a minority of patients requires placement of CSF diversion shunts to preserve vision.

Related Links:
Swansea University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.